Biotechnology.report

Integrated DNA Technologies, a global genomics leader, opens its Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa, signalling its entry into the therapeutics field. From research to cGMP-grade cell and gene therapy reagents, IDT serves as the one-stop partner to expedite the journey from lab to therapeutic development for researchers.

Click here to read the full article now: https://bit.ly/46CJoEB

Integrated DNA Technologies Opens New Therapeutic Manufacturing Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation

Immunic Therapeutics, a biotech company, has announced positive interim data from its phase 2 CALLIPER trial of vidofludimus calcium in patients with progressive multiple sclerosis (PMS).

Click the link below to read the full news:
https://bit.ly/46npBZS

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial Immunic, Inc. a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic

NKGen Biotech, Inc. has achieved a significant breakthrough in biotechnology. The first patient has been dosed in their groundbreaking Phase I clinical trial, marking a crucial step forward in the development of innovative NK cell therapies.

Click the link below and read the full news:
https://tinyurl.com/4dnjwkwc

NKGen Biotech, Inc. Announces First Patient Dosed in Phase NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic

Aspen Neuroscience, Inc. teams up with Emerald Innovations and Rune Labs to introduce groundbreaking digital health modalities into the Trial-Ready Screening Cohort Study.

Dive into the full news to get an in-depth look at this groundbreaking endeavor:
https://tinyurl.com/mr2mfu93